|
|
|
Insider
Information: |
Labrucherie Gil M |
Relationship: |
Chief Financial Officer |
City: |
San Carlos |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
319,155 |
|
Indirect Shares
|
94,335 |
|
|
Direct
Value |
$377,825 |
|
|
Indirect Value
|
$460,355 |
|
|
Total
Shares |
413,490 |
|
|
Total
Value |
$838,179 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Nektar Therapeutics |
NKTR |
SVP, COO & CFO |
2022-05-16 |
312,905 |
2008-11-14 |
0 |
Premium* |
|
Rezolute, Inc |
RZLT |
Director |
2022-05-04 |
0 |
2022-05-04 |
53,572 |
Premium* |
|
Acelyrin, Inc. |
SLRN |
Chief Financial Officer |
2023-10-04 |
6,250 |
2023-10-04 |
40,763 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
104 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SLRN |
Acelyrin, Inc. |
Interim CFOOfficer |
|
2023-08-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,250 |
|
% |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2008-11-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,122 |
2,369 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2008-11-14 |
4 |
S |
$4.37 |
$1,752 |
D/D |
(401) |
1,968 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2009-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,089 |
3,057 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2009-05-12 |
4 |
S |
$5.57 |
$2,200 |
D/D |
(395) |
2,662 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2011-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,089 |
3,057 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2014-11-03 |
4 |
OE |
$11.38 |
$112,662 |
D/D |
9,900 |
13,651 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2014-11-03 |
4 |
AS |
$13.78 |
$136,422 |
D/D |
(9,900) |
3,751 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2014-11-24 |
4 |
AS |
$15.04 |
$157,920 |
D/D |
(10,500) |
3,751 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2014-11-24 |
4 |
OE |
$13.02 |
$136,710 |
D/D |
10,500 |
14,251 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2014-11-28 |
4 |
AS |
$17.02 |
$1,531,800 |
D/D |
(90,000) |
4,251 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2014-11-28 |
4 |
OE |
$4.65 |
$418,500 |
D/D |
90,000 |
94,251 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2014-12-01 |
4 |
OE |
$4.65 |
$139,500 |
D/D |
30,000 |
34,251 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2014-12-01 |
4 |
AS |
$17.00 |
$510,000 |
D/D |
(30,000) |
4,251 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2015-07-14 |
4 |
AS |
$11.78 |
$392,675 |
D/D |
(33,334) |
4,251 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2015-07-14 |
4 |
OE |
$6.98 |
$232,671 |
D/D |
33,334 |
37,585 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2015-08-13 |
4 |
OE |
$6.98 |
$232,664 |
D/D |
33,333 |
38,084 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2015-08-13 |
4 |
AS |
$10.89 |
$362,996 |
D/D |
(33,333) |
4,751 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2015-09-23 |
4 |
OE |
$6.46 |
$308,027 |
D/D |
44,999 |
49,750 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2015-09-23 |
4 |
AS |
$13.04 |
$586,787 |
D/D |
(44,999) |
4,751 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2015-10-06 |
4 |
OE |
$6.46 |
$308,033 |
D/D |
45,000 |
49,751 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2015-10-06 |
4 |
AS |
$10.99 |
$494,550 |
D/D |
(45,000) |
4,751 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2015-11-11 |
4 |
OE |
$6.46 |
$308,033 |
D/D |
45,000 |
49,751 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2015-11-11 |
4 |
AS |
$13.52 |
$608,400 |
D/D |
(45,000) |
4,751 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & General Counsel |
|
2015-12-03 |
4 |
OE |
$6.46 |
$308,040 |
D/D |
45,001 |
50,252 |
0 |
- |
|
104 Records found
|
|
Page 1 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|